Dear Colleagues and Friends, Maxillofacial surgery stands today at a particularly meaningful crossroads. Our speciality, historically rooted in the management of trauma, infection and congenital deformities, is now experiencing a profound expansion of its scope, its responsibilities and its intellectual horizons. This evolution is not merely technical; it is philosophical, ethical and societal. One of the most striking contemporary shifts is the progressive convergence of functional reconstruction and aesthetic restoration. In the past, these domains were often perceived as distinct – sometimes even opposed. Today, they are increasingly understood as inseparable. Whether addressing post-oncologic defects, facial paralysis, orthognathic discrepancies or trauma sequelae, our patients expect not only restoration of function but also reintegration of identity, expression and social confidence. This holistic expectation has reshaped both surgical planning and outcome assessment, pushing us beyond traditional metrics towards patient-reported outcomes and quality-of-life-centered care. Facial transplantation exemplifies this paradigm shift. Beyond its extraordinary technical complexity, it forces us to confront fundamental questions about identity, consent, long-term immunosuppression and societal perceptions of ‘normality’. While still reserved for highly selected cases, facial transplantation has already transformed our understanding of what is surgically and ethically possible. More importantly, it has catalysed innovation in microsurgery, immunomodulation, nerve regeneration and interdisciplinary collaboration – advances that now benefit a far broader patient population. At the same time, digital technologies are quietly but profoundly reshaping daily practice. Virtual surgical planning, three-dimensional printing, navigation systems and artificial intelligence are no longer experimental tools; they are becoming integral to precision, predictability and safety. These technologies democratise expertise, allowing complex procedures to be standardised and shared across continents. For colleagues in regions with limited access to subspeciality training, such tools offer unprecedented opportunities to elevate care while maintaining local autonomy. However, technological progress alone is insufficient. The future of maxillofacial surgery will depend equally on education, mentorship and global collaboration. The rapid dissemination of knowledge through open-access journals, international societies and digital platforms has reduced traditional academic hierarchies. Today, innovation may emerge from any corner of the world. It is our collective responsibility – particularly as senior surgeons and educators – to ensure that this knowledge exchange remains rigorous, ethical and inclusive, with particular attention to the needs and realities of the Global South. Finally, we must acknowledge the changing expectations of younger generations of surgeons. They seek not only technical excellence but also meaning, balance and ethical coherence in their professional lives. Addressing burnout, fostering diversity and promoting compassionate leadership are no longer peripheral concerns; they are central to the sustainability of our speciality. In this era of rapid transformation, maxillofacial surgery must remain anchored in its core values: scientific rigor, surgical humility and deep respect for the human face as both a functional organ and the primary vessel of identity. By embracing innovation while preserving these principles, our speciality is uniquely positioned to lead – not only within surgery but also within medicine as a whole. With sincere regards, Prof. Jean-Paul Meningaud, MD, PhD President Elect, ICMFS
Jean-Paul Meningaud (Tue,) studied this question.